Related Experiment Video
Updated: Jun 7, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
A kernelisation approach for multiple d-Hitting Set and its application in optimal multi-drug therapeutic
Drew Mellor1, Elena Prieto, Luke Mathieson
1Centre for Bioinformatics, Biomarker Discovery and Information Based Medicine, The University of Newcastle, Newcastle, Australia.
Abstract:
Therapies consisting of a combination of agents are an attractive proposition, especially in the context of diseases such as cancer, which can manifest with a variety of tumor types in a single case. However uncovering usable drug combinations is expensive both financially and temporally. By employing computational methods to identify candidate combinations with a greater likelihood of success we can avoid these problems, even when the amount of data is prohibitively large. Hitting Set is a combinatorial problem that has useful application across many fields, however as it is NP-complete it is traditionally considered hard to solve exactly. We introduce a more general version of the problem (α,β,d)-Hitting Set, which allows more precise control over how and what the hitting set targets. Employing the framework of Parameterized Complexity we show that despite being NP-complete, the (α,β,d)-Hitting Set problem is fixed-parameter tractable with a kernel of size O(αdk(d)) when we parameterize by the size k of the hitting set and the maximum number α of the minimum number of hits, and taking the maximum degree d of the target sets as a constant. We demonstrate the application of this problem to multiple drug selection for cancer therapy, showing the flexibility of the problem in tailoring such drug sets. The fixed-parameter tractability result indicates that for low values of the parameters the problem can be solved quickly using exact methods. We also demonstrate that the problem is indeed practical, with computation times on the order of 5 seconds, as compared to previous Hitting Set applications using the same dataset which exhibited times on the order of 1 day, even with relatively relaxed notions for what constitutes a low value for the parameters. Furthermore the existence of a kernelization for (α,β,d)-Hitting Set indicates that the problem is readily scalable to large datasets.
Insights
Computational methods can identify effective cancer drug combinations faster and more affordably. We introduce a new Hitting Set problem formulation that is computationally tractable for practical applications in drug discovery.
Area of Science:
- Computational biology
- Combinatorial optimization
- Cancer therapy
Background:
- Developing effective combination therapies for complex diseases like cancer is crucial but costly.
- Traditional methods for identifying drug combinations are time-consuming and expensive.
- Computational approaches can accelerate the discovery of promising drug combinations.
Purpose of the Study:
- To introduce a generalized Hitting Set problem, termed (α,β,d)-Hitting Set, for efficient drug combination selection.
- To analyze the computational complexity of the (α,β,d)-Hitting Set problem using Parameterized Complexity.
- To demonstrate the practical applicability and scalability of this new method in cancer therapy.
Main Methods:
- Formulated the (α,β,d)-Hitting Set problem, a generalization of the standard Hitting Set problem.
- Applied Parameterized Complexity theory to prove fixed-parameter tractability for the (α,β,d)-Hitting Set problem.
- Developed a kernelization for the problem with a kernel size of O(αdk(d)).
Main Results:
- The (α,β,d)-Hitting Set problem is NP-complete but fixed-parameter tractable.
- A kernelization exists, indicating scalability to large datasets.
- Practical application in cancer drug selection yielded computation times of approximately 5 seconds, significantly faster than previous methods.
Conclusions:
- The (α,β,d)-Hitting Set problem offers a computationally efficient and scalable approach for identifying optimal drug combinations.
- This method accelerates drug discovery for complex diseases like cancer, reducing financial and temporal costs.
- The fixed-parameter tractability and kernelization demonstrate the practical utility and scalability of the proposed computational framework.
Related Concept Videos
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Drug Discovery: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Bioequivalence of Drugs: Drugs with Multiple Indications

